Cara Therapeutics, Inc.

Historical 13F Holders

Symbol
CARA
CUSIP
140755109
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 1 20.2 k $7.16 k
2024 Q3 71 13.5 M $4.17 M
2024 Q2 87 17.8 M $4.60 M
2024 Q1 106 23.9 M $21.9 M
2023 Q4 119 24.9 M $18.5 M
2023 Q3 128 27.1 M $45.6 M
2023 Q2 144 29.4 M $83.4 M
2023 Q1 170 33.9 M $167 M
2022 Q4 173 35.8 M $384 M
2022 Q3 173 34.6 M $324 M
2022 Q2 191 34.8 M $318 M
2022 Q1 198 31.8 M $387 M
2021 Q4 203 30.7 M $373 M
2021 Q3 187 29.6 M $457 M
2021 Q2 192 31.1 M $444 M
2021 Q1 191 32.4 M $704 M
2020 Q4 174 32.8 M $496 M
2020 Q3 173 33.4 M $425 M
2020 Q2 161 32.7 M $560 M
2020 Q1 152 32.3 M $426 M
2019 Q4 170 31.9 M $514 M
2019 Q3 160 30.5 M $558 M
2019 Q2 151 26.8 M $575 M
2019 Q1 159 22.3 M $438 M
2018 Q4 152 24.6 M $320 M
2018 Q3 170 24.2 M $580 M
2018 Q2 153 19.6 M $368 M
2018 Q1 133 18.1 M $224 M
2017 Q4 138 17.2 M $211 M
2017 Q3 136 19.1 M $262 M
2017 Q2 165 19.9 M $307 M
2017 Q1 138 17.4 M $319 M
2016 Q4 109 13.9 M $130 M
2016 Q3 87 11.6 M $96.9 M
2016 Q2 72 13.3 M $120 M
2016 Q1 96 16.3 M $102 M
2015 Q4 101 20.3 M $341 M
2015 Q3 94 18.6 M $271 M
2015 Q2 76 12.1 M $147 M
2015 Q1 60 11.1 M $112 M
2014 Q4 56 10.4 M $104 M
2014 Q3 57 9.72 M $81.5 M
2014 Q2 50 8.80 M $150 M
2014 Q1 42 8.62 M $160 M